Speakers

Speaker profile

Mark is CEO at IBioIC and is responsible for its strategy and delivery of activities to grow the UK bioeconomy. IBioIC’s role is to engage, collaborate with and support large corporates, SMEs, academia and Government to accelerate and de-risk commercialisation, and to bring new biotechnology processes and products to market.

Mark joined IBioIC from CPI where he was Business Development Director for the £38M National Biologics Manufacturing Centre in Darlington. Prior to this he was the Medicines Manufacturing Specialist at the Knowledge Transfer Network (KTN), and worked for seven years developing the growth of bioprocessing across the UK as part of the bioProcessUK network, within the BioIndustry Association. Mark has also been a steering group member for the Medicines Manufacturing Industry Partnership and led the secretariat function for the UK’s Advanced Therapies Manufacturing Taskforce for the past Minister for Science, George Freeman MP.